MOH — authorised 17 November 1973
- Marketing authorisation holder: GE HEALTHCARE
- Status: likely_approved
MOH authorised Metrizoate on 17 November 1973
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 17 November 1973.
GE HEALTHCARE holds the Israeli marketing authorisation.